Compare SNAL & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNAL | RGNT |
|---|---|---|
| Founded | 2000 | 2004 |
| Country | United States | Israel |
| Employees | N/A | 8 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.6M | 24.6M |
| IPO Year | 2022 | N/A |
| Metric | SNAL | RGNT |
|---|---|---|
| Price | $5.19 | $2.20 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 680.8K | 677.4K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 120.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $81,225,622.00 | N/A |
| Revenue This Year | $15.53 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.34 | $1.23 |
| 52 Week High | $5.92 | $15.50 |
| Indicator | SNAL | RGNT |
|---|---|---|
| Relative Strength Index (RSI) | 84.21 | 40.11 |
| Support Level | $0.65 | $1.82 |
| Resistance Level | N/A | $3.35 |
| Average True Range (ATR) | 0.50 | 0.45 |
| MACD | 0.36 | -0.26 |
| Stochastic Oscillator | 89.42 | 2.74 |
Snail Inc is an independent developer and publisher of interactive digital entertainment for consumers around the world, with a portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States. The Company has one operating and reportable segment. The company operates in the USA, the UK and Other Countries.
Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.